Roundhill Glp-1 & Weight Loss ETF OZEM

$26.58 +0.08 (0.30%)

Valuation

Market cap
—
Revenue TTM
—
Net income TTM
—
P/E (trailing)
—
P/E (forward)
—
Profit margin
—
Debt to equity
—

Trading

Volume
14,604
Avg volume
—
Day's range
$26.43 – $26.70
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Latest news

Stocktwits

StocktwitsNews Oct 30, 7:13 PM
LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today $LLY $ABBV $OZEM https://stocktwits.com/news/equity/markets/lly-abbv-stocks-hit-all-time-high-here-s-what-s-driving-investor-enthusiasm-today/cZUL2RQR9cd
0 replies
StocktwitsNews Oct 29, 12:24 PM
Eli Lilly CEO Cites Growth Beyond Weight Loss In Oncology, Immunology As Key To FY 2026 Outlook Raise – LLY Stock Surges To Record High In Pre-Market $LLY $NVO $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-ceo-cites-growth-beyond-weight-loss-in-oncology-immunology-as-key-to-fy-2026-outlook-raise-lly-stock/cZUQZzqR9bs
0 replies
Pseudominds Oct 28, 12:51 PM
$LLY $NVO $OZEM if zepbound and mounjuro already winning the war on efficacy and it’s not even close. Lily is destroying novo on injectables from head to toes. If Reta came out, it will likely cannibalize meaningful lily own shares.
1 replies
StocktwitsNews Oct 28, 12:35 PM
LLY Vs NVO: Lilly’s Retatrutide Beats Novo’s Ozempic In Head-To-Head Trial — Retatrutide More Than Doubles Weight Loss $LLY $OZEM $NVO https://stocktwits.com/news/equity/markets/lly-nvo-retatrutide-beats-ozempic-in-head-to-head-trial/cZU9h53R9GR
1 replies
TechForz Oct 20, 2:37 PM
$OZEM it’s time for med stocks to rise!
0 replies
StocktwitsNews Oct 16, 3:41 PM
Lilly’s Foundayo Pill Gets European Regulatory Backing – LLY Stock Heads For Best Week In Nearly Four Months $LLY $OZEM https://stocktwits.com/news/equity/markets/lilly-foundayo-pill-gets-european-regulatory-backing-lly-stock/cZxK4fORBso
0 replies
StocktwitsNews Oct 14, 12:53 PM
Viking’s Key Obesity Pill Enters Phase 3 Trial – Here’s What Investors Need To Know $VKTX $LLY $OZEM $NVO https://stocktwits.com/news/equity/markets/viking-obesity-pill-enters-phase-3-trial-vk2735/cZxf8k8RBqG
0 replies
ripster47 Oct 5, 3:31 PM
$OZEM GLP-1 and Weight Loss Sector been Red for day in row This sector is not going anywhere! Keep eyes
0 replies